FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1880849957> ?p ?o ?g. }

• W1880849957 endingPage "480" @default.
• W1880849957 startingPage "471" @default.
• W1880849957 abstract "Multiple exercise interventions have shown beneficial effects on fatigue and quality of life (QoL) in cancer patients, but various psychosocial interventions as well. It is unclear to what extent the observed effects of exercise interventions are based on physical adaptations or rather on psychosocial factors associated with supervised, group-based programs. It needs to be determined which aspects of exercise programs are truly effective. Therefore, we aimed to investigate whether resistance exercise during chemotherapy provides benefits on fatigue and QoL beyond potential psychosocial effects of group-based interventions. One-hundred-one breast cancer patients starting chemotherapy were randomly assigned to resistance exercise (EX) or a relaxation control (RC) group. Both interventions were supervised, group-based, 2/week over 12 weeks. The primary endpoint fatigue was assessed with a 20-item multidimensional questionnaire, QoL with the EORTC QLQ-C30/BR23. Analyses of covariance for individual changes from baseline to Week 13 were calculated. In RC, total and physical fatigue worsened during chemotherapy, whereas EX showed no such impairments (between-group p = 0.098 and 0.052 overall, and p = 0.038 and 0.034 among patients without severe baseline depression). Differences regarding affective or cognitive fatigue were not significant. Benefits of EX were also seen to affect role and social function. Effect sizes were between 0.43 and 0.48. Explorative analyses indicated significant effect modification by thyroxin use (p-interaction = 0.044). In conclusion, resistance exercise appeared to mitigate physical fatigue and maintain QoL during chemotherapy beyond psychosocial effects inherent to supervised group-based settings. Thus, resistance exercise could be an integral part of supportive care for breast cancer patients undergoing chemotherapy." @default.
• W1880849957 created "2016-06-24" @default.
• W1880849957 creator A5016535463 @default.
• W1880849957 creator A5018121686 @default.
• W1880849957 creator A5026586859 @default.
• W1880849957 creator A5070299067 @default.
• W1880849957 creator A5088637817 @default.
• W1880849957 creator A5089392438 @default.
• W1880849957 date "2014-12-16" @default.
• W1880849957 modified "2023-10-16" @default.
• W1880849957 title "Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: A randomized controlled trial" @default.
• W1880849957 cites W1494692328 @default.
• W1880849957 cites W1884023183 @default.
• W1880849957 cites W1897720113 @default.
• W1880849957 cites W1963821095 @default.
• W1880849957 cites W1968508379 @default.
• W1880849957 cites W2003497549 @default.
• W1880849957 cites W2008236720 @default.
• W1880849957 cites W2009828336 @default.
• W1880849957 cites W2010900822 @default.
• W1880849957 cites W2017807670 @default.
• W1880849957 cites W2025354391 @default.
• W1880849957 cites W2041918383 @default.
• W1880849957 cites W2045959509 @default.
• W1880849957 cites W2053692867 @default.
• W1880849957 cites W2054200022 @default.
• W1880849957 cites W2059185100 @default.
• W1880849957 cites W2065422476 @default.
• W1880849957 cites W2080227501 @default.
• W1880849957 cites W2081941657 @default.
• W1880849957 cites W2086223707 @default.
• W1880849957 cites W2095865487 @default.
• W1880849957 cites W2102992960 @default.
• W1880849957 cites W2103607521 @default.
• W1880849957 cites W2112395080 @default.
• W1880849957 cites W2115772710 @default.
• W1880849957 cites W2117207392 @default.
• W1880849957 cites W2125398770 @default.
• W1880849957 cites W2133026620 @default.
• W1880849957 cites W2139213802 @default.
• W1880849957 cites W2141966658 @default.
• W1880849957 cites W2149568734 @default.
• W1880849957 cites W2150456075 @default.
• W1880849957 cites W2153616752 @default.
• W1880849957 cites W2155897243 @default.
• W1880849957 cites W2160926137 @default.
• W1880849957 cites W2165930815 @default.
• W1880849957 cites W2167571044 @default.
• W1880849957 cites W335648507 @default.
• W1880849957 doi "https://doi.org/10.1002/ijc.29383" @default.
• W1880849957 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25484317" @default.
• W1880849957 hasPublicationYear "2014" @default.
• W1880849957 type Work @default.
• W1880849957 sameAs 1880849957 @default.
• W1880849957 citedByCount "195" @default.
• W1880849957 countsByYear W18808499572015 @default.
• W1880849957 countsByYear W18808499572016 @default.
• W1880849957 countsByYear W18808499572017 @default.
• W1880849957 countsByYear W18808499572018 @default.
• W1880849957 countsByYear W18808499572019 @default.
• W1880849957 countsByYear W18808499572020 @default.
• W1880849957 countsByYear W18808499572021 @default.
• W1880849957 countsByYear W18808499572022 @default.
• W1880849957 countsByYear W18808499572023 @default.
• W1880849957 crossrefType "journal-article" @default.
• W1880849957 hasAuthorship W1880849957A5016535463 @default.
• W1880849957 hasAuthorship W1880849957A5018121686 @default.
• W1880849957 hasAuthorship W1880849957A5026586859 @default.
• W1880849957 hasAuthorship W1880849957A5070299067 @default.
• W1880849957 hasAuthorship W1880849957A5088637817 @default.
• W1880849957 hasAuthorship W1880849957A5089392438 @default.
• W1880849957 hasConcept C118552586 @default.
• W1880849957 hasConcept C121608353 @default.
• W1880849957 hasConcept C126322002 @default.
• W1880849957 hasConcept C150966472 @default.
• W1880849957 hasConcept C159110408 @default.
• W1880849957 hasConcept C168563851 @default.
• W1880849957 hasConcept C1862650 @default.
• W1880849957 hasConcept C27415008 @default.
• W1880849957 hasConcept C2778141389 @default.
• W1880849957 hasConcept C2779951463 @default.
• W1880849957 hasConcept C530470458 @default.
• W1880849957 hasConcept C71924100 @default.
• W1880849957 hasConceptScore W1880849957C118552586 @default.
• W1880849957 hasConceptScore W1880849957C121608353 @default.
• W1880849957 hasConceptScore W1880849957C126322002 @default.
• W1880849957 hasConceptScore W1880849957C150966472 @default.
• W1880849957 hasConceptScore W1880849957C159110408 @default.
• W1880849957 hasConceptScore W1880849957C168563851 @default.
• W1880849957 hasConceptScore W1880849957C1862650 @default.
• W1880849957 hasConceptScore W1880849957C27415008 @default.
• W1880849957 hasConceptScore W1880849957C2778141389 @default.
• W1880849957 hasConceptScore W1880849957C2779951463 @default.
• W1880849957 hasConceptScore W1880849957C530470458 @default.
• W1880849957 hasConceptScore W1880849957C71924100 @default.
• W1880849957 hasIssue "2" @default.
• W1880849957 hasLocation W18808499571 @default.
• W1880849957 hasLocation W18808499572 @default.

• next